Allergy Therapeutics PLC (LSE:AGY) - Share price - Overview

Stock Report

Allergy Therapeutics PLC AGY

Last Price
GBX29.75

Day Change
0.00|0.00%

As of 19/01/2018
15:13:24 GMT | GBX
Minimum 15 Minutes Delay.

Last Close29.75p
Day Range29.20 - 29.89
Mkt Cap176.80Mil
52-Wk Range23.00 - 39.50
Yield %0.00
ISINGB00B02LCQ05
Volume30,630
P/E-74.19
P/S2.75
P/CF804.05

Share Price

Total Returns 19/01/2018

 Chg (%)  
More ...
Allergy Therapeutics PLC6.25 
FTSE 100 TR GBP2.61
 
Financials
201520162017
More ...
Income Statement
Turnover43.2348.5164.14
Operating Profit0.73-11.95-1.90
Net Profit0.11-13.07-2.48
Reported EPS0.02-2.29-0.42
Balance Sheet
Current Assets33.7937.6137.46
Non Current Assets16.9119.0719.72
Total Assets50.7056.6857.18
Current Liabilities7.4212.5214.02
Total Liabilities16.2326.3627.22
Total Equity34.4730.3229.97
Cash Flow
Operating Cash Flow2.48-11.541.50
Net Change in Cash19.42-0.79-1.95
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2018-8.70-1.46--20.38---
2019-5.62-0.93--32.16---

Company Profile

Allergy Therapeutics PLC is a pharmaceutical products company. It develops therapies for allergy based diseases, having its primary market in Germany.

Sector

Drug Manufacturers - Major

Market Position

757 of 1835 Companies

Index

FTSE AIM All Share

Outlook

(19/10/2017) ceo - "The board and the executive team remains confident about the group's future growth potential"

Next Event 29/03/2018

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)-25.5914.145.53
Div Yld (E)0.004.064.03
PEG (E)0.00-0.460.98
ROCE-4.69179.53180.33
Op Mrgn-4.77-8.37-126.27
EPS Grwth0.005.7922.39
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy2
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Peter Jensen
Chief Executive OfficerMr. Manuel Llobet
Finance DirectorMr. Nick Wykeman
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.